Related Experiment Video
Updated: Aug 20, 2026

Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Natalie C Direkze1, Kairbaan Hodivala-Dilke, Rosemary Jeffery
1Cancer Research United Kingdom, London Research Institute, London, UK. natalie.direkze@cancer.org.uk
Abstract:
The role of myofibroblasts in tissue repair and fibrosis is well documented, but the source of these myofibroblasts is unclear. There is evidence of a circulating population of fibrocytes that can home to areas of injury and contribute to myofibroblast populations. Previously, we have shown that the bone marrow is a source of myofibroblasts for many tissues including the gut, lung, and kidney and that this phenomenon is exacerbated by injury. We now show that the bone marrow can contribute to myofibroblast and fibroblast populations in tumor stroma in a mouse model of pancreatic insulinoma. Mice transgenic for the rat insulin promoter II gene linked to the large-T antigen of SV40 (RIPTag) develop solid beta-cell tumors of the pancreas. Approximately 25% of myofibroblasts in these pancreatic tumors were donor-derived, and these were concentrated toward the edge of the tumor. Thus, the development of tumor stroma is at least in part a systemic response that may ultimately yield methods of targeting new therapy.
Insights
Bone marrow contributes to myofibroblast populations in pancreatic tumors. This systemic response in tumor stroma suggests potential therapeutic targets for cancer therapy.
Area of Science:
- Oncology
- Stem Cell Biology
- Tissue Repair
Background:
- Myofibroblasts are crucial in tissue repair and fibrosis, but their origin remains debated.
- Fibrocytes are circulating cells that may differentiate into myofibroblasts at injury sites.
- Previous research identified bone marrow as a myofibroblast source in various organs, exacerbated by injury.
Purpose of the Study:
- To investigate if bone marrow contributes to myofibroblast and fibroblast populations within pancreatic tumor stroma.
- To explore the systemic contribution of bone marrow-derived cells to tumor microenvironment development.
Main Methods:
- Utilized a RIPTag transgenic mouse model that spontaneously develops pancreatic beta-cell tumors (insulinoma).
- Employed lineage tracing to identify donor-derived cells within the tumor stroma.
- Quantified the contribution of bone marrow-derived myofibroblasts and fibroblasts to the tumor microenvironment.
Main Results:
- Approximately 25% of myofibroblasts within pancreatic tumors were derived from the bone marrow donor.
- Bone marrow-derived myofibroblasts were predominantly localized at the tumor periphery.
- Demonstrated that tumor stroma development involves a systemic contribution from the bone marrow.
Conclusions:
- The bone marrow is a significant source of myofibroblasts and fibroblasts contributing to pancreatic tumor stroma.
- Tumor stroma formation is, in part, a systemic response involving bone marrow-derived cells.
- These findings suggest potential therapeutic strategies targeting bone marrow-derived cells for pancreatic cancer treatment.
Related Concept Videos
Introduction to Fibroblasts
The Tumor Microenvironment
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Differentiation of Common Myeloid Progenitor Cells

